BCM
Burrage Capital Management Portfolio holdings
AUM
$99.7M
1-Year Return
65.92%
This Quarter Return
+15.05%
1 Year Return
+65.92%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$99.7M
AUM Growth
-$22.8M
(-19%)
Cap. Flow
-$25.5M
Cap. Flow
% of AUM
-25.56%
Top 10 Holdings %
Top 10 Hldgs %
70.67%
Holding
28
New
3
Increased
3
Reduced
2
Closed
6
Top Buys
| 1 |
Amicus Therapeutics
FOLD
|
$4.82M |
| 2 |
Verastem
VSTM
|
$2.87M |
| 3 |
EPZM
Epizyme, Inc
EPZM
|
$2.26M |
| 4 |
Revolution Medicines
RVMD
|
$1.59M |
| 5 |
INZY
Inozyme Pharma
INZY
|
$1.24M |
Top Sells
| 1 |
Protalix BioTherapeutics
PLX
|
$9.48M |
| 2 |
PTC Therapeutics
PTCT
|
$7.59M |
| 3 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$5.47M |
| 4 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
$3.91M |
| 5 |
Fulcrum Therapeutics
FULC
|
$3.77M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Apellis Pharmaceuticals
APLS
$3.55B
| – | – |
-80,727
| Closed | -$3.46M |
|
|
TVRD
27
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
| – | – |
-5,000
| Closed | -$3.91M |
|
|
TCDA
28
DELISTED
Tricida, Inc. Common Stock
TCDA
| – | – |
-658,877
| Closed | -$3.49M |
|